Translational Therapeutics and Technologies

Advances in knowledge of the molecular alterations of human cancers, refinements in technologies for the generation of genetically engineered mouse models (GEMMs), and therefore the development of cancer therapies have accelerated in recent years. Progress in these fields inspires clinically relevant studies to be performed in GEMMs, through which it's possible to glean information on drug efficacy and to spot determinants of sensitivity and resistance to drugs and drug combinations.

  • High-Resolution Microscopy
  • Mass  Spectroscopy
  • Cell-Based Assays
  • Genomics
  • Metabolomics
  • Proteomics

    Related Conference of Translational Therapeutics and Technologies

    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 21-22, 2025

    24th International Conference on Genomics and Molecular Biology

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France
    August 25-26, 2025

    8th International Conference on Community Nursing and Public Health

    Singapore City, Singapore
    September 19-20, 2025

    9th International Conference on Internal Medicine

    Aix-en-Provence, France
    September 22-23, 2025

    39th International Conference on Cancer Science & Therapy

    Amsterdam, Netherlands
    September 22-23, 2025

    17th Annual Congress on Drug Formulation & Analytical Techniques

    Amsterdam, Netherlands
    October 06-07, 2025

    19th International Conference on Obesity Medicine

    London, UK
    October 16-17, 2025

    19th International Conference on Pathology and Laboratory Medicine

    Aix-en-Provence, France
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy
    November 21-22, 2025

    5th International Conference on Medical Research and Development

    Amsterdam, Netherlands

    Translational Therapeutics and Technologies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in